Join us at this year's virtual ISCT Annual Meeting, a yearly summit for representatives in the field of cell and gene therapy to discuss the aims, policies, and solutions driving the clinical translation of cellular therapies into safe and effective ones that reach the market.
Dr. Dominic Clarke, Director Global Cell Therapy & Innovation Global Strategic Planning at Charles River, and ISCT Process & Product Committee Co-Chair, will be chairing and moderating the session:
Program Track II
Commercialization Allogeneic Therapies – What Really is a Healthy Donor?
May 26, 2021 – 10:00 EDT
Rapid Microbiological Testing of Biologics Products Using ATP Bioluminescence
Featured Poster Presenter
Senior Manager, Celsis® Technical Services and Validations
For more information, please contact us at [email protected].